Expanding the National Rare Disease Infrastructure
The National Organization for Rare Disorders (NORD) has announced three new additions to its national Rare Disease Centers of Excellence (RD CoE) Network. For the inherited retinal disease (IRD) community and others impacted by rare conditions, the continuous expansion of coordinated clinical and research resources represents a significant step toward addressing fragmented care.
According to BioSpace, the recent additions bring the total number of designated centers in the network to 49. These members span 28 states and the District of Columbia, maintaining affiliations with over 170 academic medical centers, research institutions, and children's hospitals nationwide. The newly designated institutions include Atrium Health in North Carolina, Northwell Health/Cohen Children's Medical Center in New York, and UC San Diego & Rady Children's Health San Diego in California.
What This Means for Patients and Families
With more than 10,000 rare diseases identified and hundreds more recognized each year, clinical expertise and research opportunities often remain scattered. NORD's network is designed to transform individual organizational capabilities into a shared national infrastructure. Each center undergoes a rigorous designation process, meeting specific benchmarks for comprehensive genetics and metabolic services, coordinated pediatric and adult care, rare disease research, workforce training, and community education.
For patients and families navigating complex or rare diagnoses, the network aims to foster collaboration across institutional and geographic boundaries, helping to streamline expert care and connect individuals with relevant research initiatives.
Looking Ahead
As NORD's Rare Disease Centers of Excellence Network continues to grow, participating institutions will maintain their focus on collaborative problem-solving, cross-network case conferences, and advancing clinical research to support the millions of Americans living with rare conditions.